Israel Englander Zymeworks Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $895,720 - $1.43 Million	192,628 New	192,628 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $5.71 Million - $9.12 Million	-1,184,831 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $4.02 Million - $11.4 Million	669,916 Added 130.1%	1,184,831 $7.76 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $4.18 Million - $8.07 Million	275,102 Added 114.72%	514,915 $8.44 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $5.52 Million - $7.52 Million	201,807 Added 530.99%	239,813 $6.96 Million
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $1.5 Million - $2.17 Million	-56,730 Reduced 59.88%	38,006 $1.32 Million
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $3.43 Million - $6.53 Million	-114,877 Reduced 54.8%	94,736 $2.99 Million
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $1.23 Million - $1.72 Million	-31,325 Reduced 13.0%	209,613 $9.91 Million
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $422,551 - $673,826	14,466 Added 6.39%	240,938 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $2.38 Million - $2.82 Million	70,571 Added 45.27%	226,472 $8.17 Million
Q1 2020 May 14, 2020	SELL	$24.28 - $49.8 $7.06 Million - $14.5 Million	-290,661 Reduced 65.09%	155,901 $5.53 Million
Q4 2019 Feb 14, 2020	SELL	$24.84 - $45.46 $23.2 Million - $42.4 Million	-933,195 Reduced 67.63%	446,562 $20.3 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $29.08 $2.95 Million - $3.76 Million	129,412 Added 10.35%	1,379,757 $34.2 Million
Q2 2019 Aug 15, 2019	BUY	$15.0 - $22.49 $18.7 Million - $28.1 Million	1,248,671 Added 74592.05%	1,250,345 $27.5 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $22.49 $708,990 - $1.06 Million	-47,266 Reduced 96.58%	1,674 $1.43 Million
Q1 2019 May 14, 2019	BUY	$14.02 - $16.74 $41,288 - $49,299	2,945 Added 6.4%	48,940 $792,000
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $296,887 - $418,624	-27,113 Reduced 37.09%	45,995 $675,000
Q3 2018 Nov 14, 2018	SELL	$12.21 - $16.61 $298,839 - $406,529	-24,475 Reduced 25.08%	73,108 $1.15 Million
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $1.09 Million - $2.13 Million	97,583 New	97,583 $1.44 Million
Q4 2017 Feb 14, 2018	SELL	$6.87 - $9.19 $150,913 - $201,876	-21,967 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$6.48 - $8.73 $142,346 - $191,771	21,967	21,967 $175,000

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.33 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $901M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account